The adoptive transfer of splenocytes from diabetic NOD mice to NOD-scid/scid (NOD-scid) recipients results in diabetes. This model was used to test the effect of cotransfer of splenocyte subsets from young nondiabetic NOD mice. As shown previously in other NOD models, the CD4+ subset from young nondiabetic mice significantly delayed the onset of diabetes in splenocyte cotransfers (P < 0.001). The data presented here showed that the development of diabetes in NOD-scid recipients correlated with a rapid increase in peripheral CD45RBlow CD4+ cells. However, the CD45RBlow subset of CD4+ cells from young nondiabetic mice protected from diabetes transfer in this model. We therefore examined whether CD45RBlow CD4+ cells from diabetic mice were pathogenic rather than protective. CD45RBlow CD4+ splenocytes from diabetic NOD mice were transferred along with CD8+ splenocytes from diabetic mice into NOD-scid recipients, and all of the recipients became diabetic within 5 weeks posttransfer. In contrast, no recipients (0 of 10) of CD45RBhigh CD4+ cells along with CD8+ splenocytes from diabetic mice became diabetic within 5 weeks posttransfer (P < 0.001). A correlate for the difference between CD45RBlow CD4+ cells from diabetic NOD mice and CD45RBlow CD4+ cells from nondiabetic mice, which showed protective effect in splenocyte cotransfers, was found in cytokine production after stimulation with anti-CD3 antibodies in vitro. CD45RBlow CD4+ cells from diabetic mice showed a significantly higher ratio (approx-imately fivefold) of γ-interferon (IFN-γ) to interleukin (IL)-4 when compared with CD45RBlow CD4+ cells from nondiabetic mice (P < 0.001). In conclusion, the function of the CD45RBlow population of CD4+ cells changes from a protective to a pathogenic one during the development of disease in the NOD mouse. This change in function correlates with cytokine production in vitro; increased IFN-γ-to-IL-4 ratio is associated with pathogenic potential and occurs coincident with (or after) the onset of diabetes.
Skip Nav Destination
Article navigation
Original Articles|
January 01 1996
Pathogenic and Protective Roles of CD45RBlow CD4+ Cells Correlate With Cytokine Profiles in the Spontaneously Autoimmune Diabetic Mouse Free
Akira Shimada;
Akira Shimada
Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine
Stanford, California
Search for other works by this author on:
Patricia Rohane;
Patricia Rohane
Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine
Stanford, California
Search for other works by this author on:
C Garrison Fathman;
C Garrison Fathman
Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine
Stanford, California
Search for other works by this author on:
Brett Charlton
Brett Charlton
Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine
Stanford, California
Search for other works by this author on:
Address correspondence and reprint requests to Dr. C. Garrison Fathman, Stanford University Medical Center, Department of Medicine, Division of Immunology and Rheumatology, Room S021, Stanford, CA 94305
Diabetes 1996;45(1):71–78
Article history
Received:
May 12 1995
Received:
August 24 1995
Accepted:
August 24 1995
PubMed:
8522063
Citation
Akira Shimada, Patricia Rohane, C Garrison Fathman, Brett Charlton; Pathogenic and Protective Roles of CD45RBlow CD4+ Cells Correlate With Cytokine Profiles in the Spontaneously Autoimmune Diabetic Mouse. Diabetes 1 January 1996; 45 (1): 71–78. https://doi.org/10.2337/diab.45.1.71
Download citation file:
80
Views